標普和納斯達克內在價值 聯繫我們

Abcam plc ABCM NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score
47/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Abcam plc (ABCM) 是一家上市公司 屬於 醫療保健 板塊,經營於 生物科技 產業. 公司總部位於 Cambridge, 英国. 現任CEO為 Alan Thomas Hirzel BS,.

ABCM 擁有 IPO日期為 2020-10-22, 1,760 名全職員工, 在 NASDAQ Global Select, 市值為 $5.52B.

關於 Abcam plc

Abcam plc is a life science company headquartered in Cambridge, United Kingdom, specializing in the identification, development, and distribution of reagents and tools for scientific research, diagnostics, and drug discovery. The company's product portfolio includes primary and secondary antibodies, conjugated antibodies, immunoassays, proteins and peptides, edited cell lines, and complementary research tools such as cellular activity kits and cell signaling pathway tools. Abcam serves a diverse customer base encompassing academic institutions, research institutes, and commercial entities in the pharmaceutical, biotechnology, and diagnostics sectors. With established operations across the Americas, Europe, Asia Pacific, and other regions, the company distributes its products primarily through online channels. Founded in 1998, Abcam has established itself as a key supplier of essential scientific research materials globally.

📍 Discovery Drive, Cambridge CB2 0AX 📞 44 12 2369 6000
公司詳情
所屬板塊醫療保健
細分行業生物科技
國家英国
交易所NASDAQ Global Select
貨幣USD
IPO日期2020-10-22
首席執行官Alan Thomas Hirzel BS,
員工數1,760
交易資訊
當前價格$23.99
市値$5.52B
52週區間12.48-25.32
Beta0.86
ETF
ADR
CUSIP000380204
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值,發現被低估的股票。
每週線上課程
給我們留言